Laminin interactions with the apoproteins of acute-phase HDL: preliminary mapping of the laminin binding site on serum amyloid A

References

• Husby G, Marhaug G, Dowton B, Sletten K, Sipe J D. Serum amyloid (SAA): Biochemistry, genetics and the pathogenesis of AA amyloid. Amyloid 1994; 1: 119–137
   Web of Science ®Google Scholar
• Steel D M, Whitehead A S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunology Today 1994; 15: 81–88
   PubMedGoogle Scholar
• Uhlar C M, Burgess C J, Sharp P M, Whitehead A S. Evolution of serum amyloid A (SAA) protein superfamily. Genomics 1994; 19: 228–235
   PubMed Web of Science ®Google Scholar
• Jensen L E, Hiney M P, Shields D C, Uhlar C M, Lindsay A J, Whitehead A S. Acute phase proteins in Salmonids - Evolutionary analyses and acute phase response. J. Immunol. 1997; 158: 384–392
   PubMed Web of Science ®Google Scholar
• Meek R L, Benditt E P. Rat tissue express serum amyloid A protein-related mRNAs. Proc. Natl. Acad. Sci. USA 1989; 86: 1890–1894
   PubMed Web of Science ®Google Scholar
• Lowell C A, Stearman R S, Morrow J F. Transcriptional regulation of serum amyloid A gene expression. J. Biol. Chem. 1986; 261: 8453–8461
   PubMed Web of Science ®Google Scholar
• Goldberger G, Bing D H, Sipe J D, Rits M, Colten H R. Transcriptional regulation of genes encoding the acute-phase proteins CRP, SAA and C3. J. Immunol. 1987; 138: 3967–3971
   PubMed Web of Science ®Google Scholar
• McAdam K PWJ, Sipe J D. Murine model for human secondary amyloidosis: Genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J. Exp. Med. 1976; 144: 1121–1127
   PubMed Web of Science ®Google Scholar
• Benditt E P, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc. Natl. Acad. Sci. USA 1977; 74: 4025–4028
   PubMed Web of Science ®Google Scholar
• Coetzee G A, Strachan A F, van der Westhuyzen D R, Hoppe H C, Jeenah M S, de Beer F C. Serum amyloid-containing human high density lipoprotein 3. Density, size and apolipoprotein composition. J. Biol. Chem. 1986; 261: 9644–9651
   PubMed Web of Science ®Google Scholar
• Tape C, Tan R, Nesheim M, Kisilevsky R. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand. J. Immunol. 1988; 28: 317–324
   PubMed Web of Science ®Google Scholar
• Husebbek A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in-vivo. Scand. J. Immunol. 1985; 21: 283–287
   PubMed Web of Science ®Google Scholar
• Meek R L, Hoffman J S, Benditt E P. Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation. J. Exp. Med. 1986; 163: 499–510
   PubMed Web of Science ®Google Scholar
• Kisilevsky R. Heparan sulfate proteoglycans in amyloidogenesis: An epiphenomenon. A unique factor, or the tip of a more fundamental process. Lab. Invest. 1990; 63: 589–591
   PubMed Web of Science ®Google Scholar
• McCubbin W D, Kay C M, Narindrasorasak S, Kisilevsky R. Circular-dichroism studies on two murine serum amyloid A proteins. Biochem J. 1988; 256: 775–783
   PubMed Web of Science ®Google Scholar
• de Beer M C, de Beer F C, McCubbin W D, Kay C M, Kindy M S. Structural prerequisites for serum amyloid A fibril formation. J. Biol. Chem. 1993; 268: 20606–20612
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Lemieux L J, Fraser P E, Kong X, Hultin P G, Szarek W A. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: Implications for Alzheimer's disease. Nature Medicine 1995; 1: 143–147
   PubMed Web of Science ®Google Scholar
• Fraser P E, Nguyen J T, Chin D T, Kirschner D A. Effects of sulphate ions on Alzheimer-beta/A4 peptide assemblies-implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 1992; 59: 1531–1540
   PubMed Web of Science ®Google Scholar
• Priola S A, Caughey B. Inhibition of scrapie-asso-ciated PrP accumulation. Probing the role of glycosaminogly-cans in amyloidogenesis. Mol. Neurobiol. 1994; 8: 113–120
   PubMed Web of Science ®Google Scholar
• Kelly J W, Lansbury P T. A chemical approach to elucidate the mechanism of transthyretin and p-protein amyloid fibril formation. Amyloid 1994; 1: 186–205
   Web of Science ®Google Scholar
• Brunden K R, Richter-Cook N J, Chaturvedi N, Frederickson R C. pH-dependent binding of synthetic P-amyloid peptides to glycosaminoglyeans. J. Neurochem. 1993; 61: 2147–2154
   PubMed Web of Science ®Google Scholar
• Castillo G M, Ngo C, Cummings J, Wight T N, Snow A D. Perlecan binds to the p-amyloid proteins (Aβ) of Alzheimer's disease, accelerates AP fibril formation, and maintains AP fibril stability. J. Neurochem. 1997; 69: 2452–2465
   PubMed Web of Science ®Google Scholar
• Snow A D, Kinsella M G, Parks E, Sekiguchi R T, Miller J D, Kimata K, Wight T N. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the P-amyloid protein of Alzheimer's disease. Arch. Biochem. Biophys. 1995; 320: 84–95
   PubMed Web of Science ®Google Scholar
• Leveugle B, Ding W H, Laurence F, Dehouck M P, Scanemeo A, Cecchelli R, Fillit H. Heparin oligosaccharides that pass the blood brain barrier inhibit P-amyloid precursor protein secretion and heparin binding to P-amyloid peptide. J. Neurochem. 1998; 70: 736–744
   PubMed Web of Science ®Google Scholar
• Leveugle B, Scanemeo A, Ding W, Fillit H. Binding of heparan sulfate glycosaminoglycan to β-amyloid peptide: Inhibition by potentially therapeutic polysulfated compounds. NeuroReport 1994; 5: 1389–1392
   PubMed Web of Science ®Google Scholar
• Narindrasorasak S, Lowery D, Gonzalez-DeWhitt P, Poorman R A, Greenberg B D, Kisilevsky R. High affinity interactions between the Alzheimer's beta-amyloid percursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 1991; 266: 12878–12883
   PubMed Web of Science ®Google Scholar
• Narindrasorasak S, Lowery D E, Altman R A, Gonzalez-DeWhitt P, Greenberg B D, Kisilevsky R. Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab. Invest. 1992; 67: 643–652
   PubMed Web of Science ®Google Scholar
• Narindrasorasak S, Altman R A, Gonzalez-DeWhitt P, Greenberg B D, Kisilevsky R. An interaction between basement membrane and Alzheimer's precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab. Invest. 1995; 72: 272–282
   PubMed Web of Science ®Google Scholar
• Ancsin J B, Kisilevsky R. Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A. J. Biol. Chem. 1997; 272: 406–413
   PubMed Web of Science ®Google Scholar
• Ancsin J B, Kisilevsky R. Laminin interactions important for basement membrane assembly are promoted by zinc and implicate laminin zinc finger-like sequences. J. Biol. Chem. 1996; 271: 6845–6851
   PubMed Web of Science ®Google Scholar
• Nichols W C, Dwulet F E, Liepnieks J, Benson M D. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem. Biophys. Res. Commun. 1988; 156: 762–768
   PubMed Web of Science ®Google Scholar
• Turnell W G, Sarra R, Glover I D, Baum J O, Caspi D. Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites. Mol. Biol. Med. 1986; 3: 387–407
   PubMedGoogle Scholar
• Axelrad M A, Kisilevsky R, Willmer J, Chen S J, Skinner M. Further characterization of amyloid enhancing factor. Lab. Invest. 1982; 47: 139–146
   PubMed Web of Science ®Google Scholar
• Havel R J, Eder H A, Bragdon J H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955; 34: 1345–1353
   PubMed Web of Science ®Google Scholar
• Osborne J C. Delipidation of plasma lipoproteins. Meth. Enzymol. 1986; 128: 213–222
   PubMed Web of Science ®Google Scholar
• Goldsmith M R, Rattner E C, Koehler M M, Balikov S R, Bock S C. Two-dimensional electrophoresis of small-molecular-weight proteins. Anal. Biochem. 1979; 99: 33–40
   PubMed Web of Science ®Google Scholar
• Laemmli U K. Cleavage of structural proteins during the assembly of the heads of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• de Beer M C, Beach C M, Shedlofsky S I, de Beer F C. Identification of a novel serum amyloid A protein in BALB/c mice. Biochem J. 1991; 280: 45–49
   PubMed Web of Science ®Google Scholar
• Meek R L, Eriksen N, Benditt E P. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc. Natl. Acad. Sci. USA 1992; 89: 7949–7952
   PubMed Web of Science ®Google Scholar
• Yamamoto K I, Migita S. Complete primary structure of two major murine serum amyloid A proteins deduced from cDNA sequences. Proc. Natl. Acad. Sci. USA 1985; 82: 2915–2919
   PubMed Web of Science ®Google Scholar
• Lowell C A, Potter D A, Stearman R S, Morrow J F. Structure of the murine serum amyloid A gene family. Gene conversion. J. Biol. Chem. 1986; 261: 8442–8452
   PubMed Web of Science ®Google Scholar
• Preciado-Patt L, Levartowsky D, Prass M, Hershkoviz R, Lider O, Fridkin M. Inhibtion of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A - towards understanding the physiological role of an enigmatic protein. Eur. J. Biochem. 1994; 223: 35–42
   PubMedGoogle Scholar
• Woodrow S I, Gore J, Kisilevsky R, Young I D. Type-IV collagen gene expression in experimental splenic AA amyloidosis. Amyloid and Amyloidosis, R Kisilevsky, M D Benson, B Frangione, J Gaudie, T J Mickle, I D Young. The Parthenon Publishing Group, New Jersey 1994; 195–197
   Google Scholar
• Ailles L, Kisilevsky R, Young I D. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis. Lab. Invest. 1993; 69: 443–448
   PubMed Web of Science ®Google Scholar
• Yurchenco P D, O'Rear J J. Basal lamina assembly. Curr. Opinion Cell Biol. 1994; 6: 674–681
   PubMed Web of Science ®Google Scholar
• Aumailley M. Structure and supramolecular organization of basement membrane. Kidney Int. 1995; 47: 4–7
   Web of Science ®Google Scholar
• Sletten K, Westermark P, Natvig J B. Senile cardiac amyloid is related to prealbumin. Scand. Immunol. 1980; 12: 503–506
   PubMed Web of Science ®Google Scholar
• Westermark P, Johnson K H, Westermark G T, Sletten K, Hayden D W. Bovine amyloid protein AA: isolation and amino acid sequence analysis. Comp. Biochem. Physiol. 1986; 85B: 609–614
   Google Scholar
• Rossevatn K, Andresen P K, Sletten K, Husebekk A, Husby G, Nordstoga K, Johnson K H, Westermark G T, Westermark P. The complete amino acid sequence of bovine serum amyloid protein A (SAA) and of subspecies of the tissue-deposited amyloid fibril protein A. Scand. J. Immunol. 1992; 35: 217–224
   PubMed Web of Science ®Google Scholar
• Beach C M, deBeer M C, Sipe J D, Loose L D, deBeer F C. Human serum amyloid A protein. Biochem J. 1992; 282: 615–620
   PubMed Web of Science ®Google Scholar
• Preciado-Patt L, Hershkoviz R, Fridkin M, Lider O. Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4 T cells. J. Immunol. 1996; 156: 1189–1195
   PubMed Web of Science ®Google Scholar
• Hershkoviz R, Preciado-Patt L, Lider O, Fridkin M, Dastych J, Metcalfe D D, Mekori Y A. Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. Am. J. Physiol. 1997; 273: C179–C187
   Google Scholar
• Perlmutter L S, Chui H C, Saperia D, Athanikar J. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res 1990; 508: 13–19
   PubMed Web of Science ®Google Scholar
• Perlmutter L S, Chui H C. Microangiopathy, the vascular basement membrane and Alzheimer's disease - a review. Brain Res Bull. 1990; 24: 677–686
   PubMed Web of Science ®Google Scholar
• Perlmutter L S, Barron E, Saperia D, Chiu H C. Association between vascular basement membrane components and the lesions of Alzheimer's disease. J Neurosci Res. 1991; 30: 673–681
   PubMed Web of Science ®Google Scholar
• Perlmutter L S. Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol Neurobiol. 1994; 9: 33–40
   PubMed Web of Science ®Google Scholar
• Kawahara E. The role of fibronectin in the development of experimental amyloidosis - evidence of immunohis-tochemical codistribution and binding property with serum amyloid protein - A. Am J Pathol 1989; 134: 1305–1314
   PubMed Web of Science ®Google Scholar
• Westermark G T, Norling B, Westermark P. Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis. Clin Exp Immunol 1991; 86: 150–156
   PubMed Web of Science ®Google Scholar
• Bronfman F C, Alvarez A, Morgan C, Inestrosa N C. Laminin blocks the assembly of wild type A(3 and the Dutch variant peptides into Alzheimer's fibrils. Amyloid Int. J. Exp. Clin. Invest. 1998; 5: 16–23
   PubMed Web of Science ®Google Scholar